Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1141-1150 of 1761 for

Edit search filters
  1. A Study To Assess The Effectiveness Of Osimertinib Plus Savolitinib In Patients With Locally Advanced Or Metastatic Non Small Cell Lung Cancer Who Have Progressed Following Osimertinib Treatment (SAVANNAH Study) Following Prior Osimertinib

    Rochester, MN

  2. A Study To Evaluate AuTophagy Activation For Cardiomyopathy Due To Anthracycline TReatment

    Rochester, MN

  3. OsteoCool Tumor Ablation Post-Market Study

    Rochester, MN

  4. A Study Of Catequentinib, Anlotinib In Metastatic Or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma And Synovial Sarcoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. A Study Of Nirogacestat For Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)

    Jacksonville, FL, Rochester, MN

  6. A Study To Evaluate Treatment Of Papillary Thyroid Carcinoma With Radiofrequency Ablation

    Rochester, MN

  7. AUTO1 In Relapsed Or Refractory B-ALL

    Rochester, MN

  8. A Phase 1/2a Dose-Finding Study Of PT-112 In Patients With Relapsed Or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. A Study Comparing Sublobar Resection Versus Stereotactic Ablative Radiotherapy For Lung Cancer

    Rochester, MN

  10. A Feasibility Study To Evaluate The Safety Of The TheraSphere Glioblastoma (GBM) Device In Patients With Recurrent GBM

    Jacksonville, FL

.

Mayo Clinic Footer